Want Delayed Vaccines? Vaccinomics also Reduces Vaccine Injuries

Mayo Clinic has Developed the new Research Field: Vaccinomics

Interested in doing a delayed vaccine schedule with your doctor? You are not alone. According to a Fox News report, many parents are now asking for a delayed vaccine schedule. Worried about adverse reactions from vaccines? You may have interest in a new kind of vaccination schedule. Also known as personalized vaccines, vaccinomics uses patient genetics to personalize vaccines based on genetic risk factors. Since 2008 Vaccine research by doctors at the Mayo Clinic has been including this new field of research: vaccinomics. Experts hope to utilize genetic testing to find out which patients are most at risk of getting a particular disease and who will benefit from a personalized vaccine. This topic is one of several that was discussed at the Ninth Annual World Vaccine Congress held April 20-23 in Washington D.C.

According to Dr. Gregory Poland, Professor of Medicine and Infectious Disease, College of Medicine, Mayo Clinic:

“The time may come when we will know beforehand whether or not a vaccine will work ahead of time. We know with certain drugs that if you carry certain genes that means that drug could harm you or you might metabolize the drug so fast that the typical dose wouldn’t do you any good at all and we would have to give you double the dose.

That’s the idea of individualized practice of medicine. Applying that to vaccines now, we have published several times now this new direction… the idea that we would take a genetic screening and from that be able to predict things like, ‘Is this person at risk of this disease?’ ‘Do we even need to give them a vaccine?’  ‘If we gave them a vaccine, how likely are they to respond to it?’ ‘Do they need one dose, two doses, three doses? Double the dose?’  ‘If we give this vaccine, this biologic to somebody, are they likely to have some sort of serious reaction to the vaccine, as rare as that is?’

Poland continues,

“Nevertheless, there are documented cases. They may occur one in a million times of somebody getting a live viral vaccine for example, and having a significant complication to that. What if we could predict that? And the promise of genetics and of individualized medicine it is pretty clear that we will probably be able to predict some if not all of those. We are just at the very early stages of figuring out how that might all work….”

According to Ben Hewitt’s “Autism Roulette“, published in Best Life in October 2008:

“Within a decade, vaccinomics could eliminate the final, small slice of risk that exists with immunizations (for instance, approximately one in 100,000 children suffers an allergic reaction to the MMR vaccine, and one in 14,000 experiences seizures after receiving the DTaP vaccine), he says.

“Basically, we’ll be able to say, ‘You’re susceptible to this disease, so we better make sure you’re well vaccinated’ or ‘You have a 30 percent chance of having a reaction to this vaccine, and since you are at an exceedingly low risk of this disease, let’s skip it.’” Obviously, it holds promise for identifying at-risk subgroups who might be genetically predisposed to react to specific vaccines.

Certainly there is much to learn and much to hash out in the coming years between the vaccine pushers and the growing number of folks unwilling to trust in the safety of these life saving and sometimes disease causing shots. This new field of vaccinomics shows promise and might prove useful in lowering the epidemic numbers of children contracting neurological disorders as a result of adverse reactions to vaccines. It may ease the feelings of parents requesting delayed vaccines. One thing Poland’s study does not seem to consider, however, is the effect of metal toxicity on susceptible patients.